col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


102 Results       Page 1

 [1] 
Ovid: AIDS
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―05 Vespers: A nursing origin story set in the dawn of the HIV pandemic Emily Anne Barr
2 [GO] 2024―Jan―15 Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size Maggie C. Duncan, F. Harrison Omondi, Natalie N. Kinloch, Hope R. Lapointe, Sarah Speckmaier, Nadia Moran-Garcia, et al. (+14)
3 [GO] 2024―Jan―09 How the COVID-19 pandemic and the health system's response reduced HIV testing and increased late diagnoses in Mexico Fernando Macías-González, Heleen Vermandere, Alicia Piñeirúa-Menendez, Sergio Bautista-Arredondo
4 [GO] 2024―Jan―03 The association of Changes In Depression Severity After The Onset of The Covid-19 Pandemic and Viral Non-Suppression Among People With HIV Tarfa Verinumbe, Catherine R. Lesko, Richard D. Moore, Anthony T. Fojo, Jeanne Keruly, LaQuita N. Snow, et al. (+4)
5 [GO] 2023―Nov―21 Individuals with HIV Are Likely Targets for Long COVID Iulia Filip
6 [GO] 2023―Nov―15 False-positive HIV screening tests during the COVID-19 pandemic, a passing trend? Rinat Lasmanovich, Dor Atias, Orna Mor, Uri Obolski
7 [GO] 2023―Nov―08 Impact of COVID-19-related clinic closures on HIV incidence in a multicentre study of young adult MSM and transgender women in Kenya Elizabeth Wahome, Fredrick O. Otieno, Joshua Kimani, Anders Boyd, Duncan Okall, Joseph Nzioka, et al. (+6)
8 [GO] 2023―Oct―13 Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1 Frédérique Chammartin, Alexandra Griessbach, Katharina Kusejko, Annette Audigé, Selina Epp, Marcel P. Stoeckle, et al. (+12)
9 [GO] 2023―Aug―30 Outcomes of coronavirus disease 2019-related hospitalization among people with HIV: historical cohort from the Greater Paris area multicenter hospital data warehouse Valérie Pourcher, Florence Tubach, Antoine Rozes, Samia Boussouar, Candice Estellat
10 [GO] 2023―Aug―03 More evidence for inequitable COVID-19 outcomes in people with HIV Laura Waters, Ian Woolley
11 [GO] 2023―Aug―03 Antibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328) Cecilia T. Costiniuk, Joel Singer, Terry Lee, Yannick Galipeau, Pauline S. McCluskie, Corey Arnold, et al. (+24)
12 [GO] 2023―Jul―14 Antibody and T-cell responses elicited by coronavirus disease 2019 vaccination in people with HIV-1: the case of late presenters Ali Ahmad, Suzanne Samarani, Cecilia T. Costiniuk
13 [GO] 2023―Jul―14 Incidence and severity of SARS-CoV-2 infection in children and young people with HIV in Europe
14 [GO] 2023―Jul―03 Preventing SARS-CoV-2 infection and its severe outcomes in HIV-infected people Nicola Abrescia
15 [GO] 2023―Jul―03 No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands Myrthe L. Verburgh, Marc van der Valk, Bart J.A. Rijnders, Peter Reiss, Ferdinand W.N.M. Wit
16 [GO] 2023―Jun―01 Presence of the M184I mutation after short-term exposure to azvudine for COVID-19 in people living with HIV Rui Jiang, Jianjun Sun, Bihe Zhao, Renfang Zhang, Li Liu, Jun Chen
17 [GO] 2023―May―18 COVID-19 in people with HIV in the Netherlands, the ATHENA cohort study Ferdinand WNM Wit, Peter Reiss, Bart Rijnders, Casper Rokx, Anna Roukens, Kees Brinkman, Marc van der Valk
18 [GO] 2023―May―18 Six-month immune responses to mRNA-1273 Vaccine in cART-treated late presenter people living with HIV according to previous SARS-CoV-2 Infection Matteo Augello, Valeria Bono, Roberta Rovito, Camilla Tincati, Antonella D’arminio Monforte, Giulia Marchetti
19 [GO] 2023―May―17 Cognitive concerns are a risk factor for mortality in people with human immunodeficiency virus and COVID-19 Douglas R. Wilcox, Emily A. Rudmann, Elissa Ye, Ayush Noori, Colin Magdamo, Aayushee Jain, et al. (+7)
20 [GO] 2023―Apr―18 Immunogenicity, effectiveness and safety of SARS-CoV-2 vaccination in people living with HIV: A systematic review and meta-analysis David WJ Griffin, Rekha Pai Mangalore, Jennifer F Hoy, James H Mcmahon
21 [GO] 2023―Mar―15 Effectiveness of COVID-19 primary and booster vaccination in HIV-infected individuals Bin Su, Guido Vanham
22 [GO] 2023―Feb―15 SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive ART Peter K. Cheung, Hope R. Lapointe, Yurou Sang, Siobhan Ennis, Francis Mwimanzi, Sarah Speckmaier, et al. (+10)
23 [GO] 2023―Feb―13 Increased risk of false positive HIV ELISA results after COVID-19 Laura G. Alfie, Yesica S. Longueira, Mónica Pippo, Leonel Cruces, María F. Quiroga, Gabriela Turk, Natalia Laufer
24 [GO] 2023―Feb―13 An estimate of excess deaths among people with HIV during the COVID-19 pandemic in the United States, 2020 Weiming Zhu, Ya-lin A. Huang, Ruiguang Song, Jeffrey Wiener, Robyn N. Neblett-Fanfair, Athena P. Kourtis, Karen W. Hoover
25 [GO] 2023―Feb―13 Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people living with HIV José L. Casado, Pilar Vizcarra, Sara Martín-Colmenarejo, Judith del Pino, Sandra Gomez-Maldonado, Adrían Martín-Hondarza, Alejandro Vallejo
26 [GO] 2023―Feb―02 Adverse events and SARS-CoV-2 antibody responses after immunization with sputnik V, ChAdOx1-S and BBIBP-CorV vaccines in people with HIV Romina Mauas, Analia Ureña, Diego Cecchini, Maria L. Strada, Soledad Arietti, Isabel Cassetti, et al. (+5)
27 [GO] 2023―Feb―01 The impact of COVID-19 pandemic on the dynamic HIV care engagement among people with HIV: real-world evidence Xueying Yang, Jiajia Zhang, Shujie Chen, Sharon Weissman, Bankole Olatosi, Xiaoming Li
28 [GO] 2023―Jan―25 COVID-19 vaccine immunogenicity in people with HIV: Erratum
29 [GO] 2022―Dec―22 Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, Yurou Sang, Fatima Yaseen, Sarah Speckmaier, et al. (+34)
30 [GO] 2022―Dec―21 Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people with HIV Pathum Sookaromdee, Viroj Wiwanitkit
31 [GO] 2022―Dec―08 COVID-19 vaccine immunogenicity in people with HIV Cecilia T. Costiniuk, Joel Singer, Terry Lee, Marc-André Langlois, Corey Arnold, Yannick Galipeau, et al. (+24)
32 [GO] 2022―Dec―08 T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa William C. McMahon, Gaurav Kwatra, Alane Izu, Anthonet L. Koen, Johann Greffrath, Lee Fairlie, et al. (+11)
33 [GO] 2022―Nov―16 Tenofovir disoproxil fumarate/emtricitabine and severity of coronavirus disease 2019 in people with HIV infection Julia Del Amo, Rosa Polo, Santiago Moreno, Esteban Martínez, Alfonso Cabello, José Antonio Iribarren, et al. (+10)
34 [GO] 2022―Oct―18 COVID-19 Vaccine Effectiveness among a Population-based Cohort of People Living with HIV Catharine Chambers, Hasina Samji, Curtis L. Cooper, Cecilia T. Costiniuk, Naveed Z. Janjua, Abigail E. Kroch, et al. (+15)
35 [GO] 2022―Sep―21 Outcomes following SARS-CoV-2 infection among individuals living with and without HIV; a Danish nationwide cohort study Line D. Rasmussen, Susan Cowan, Jan Gerstoft, Gitte Kronborg, Isik S. Johansen, Carsten S. Larsen, et al. (+7)
36 [GO] 2022―Sep―16 The Association between Comorbidities and COVID-19 Hospitalization among People with HIV differs by Age Caitlin A. Moran, Nora T. Oliver, Brittany Szabo, Lauren F. Collins, Minh Ly T. Nguyen, N. Sarita Shah, et al. (+9)
37 [GO] 2022―Sep―02 Humoral responses to coronavirus disease 2019 vaccines in people with HIV: authors’ reply Ngai Sze Wong, Bonnie C.K. Wong, Jacky M.C. Chan, Ka Hing Wong, Owen T.Y. Tsang, Shui Shan Lee, Denise P.C. Chan
38 [GO] 2022―Sep―02 Surrogate neutralization responses following SARS-CoV-2 vaccination in people with HIV Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
39 [GO] 2022―Aug―11 Maternal-foetal transfer of SARS-CoV-2 antibodies among women with and those without HIV infection Marta C. Nunes, Stephanie Jones, Zanele Ditse, Kelly da Silva, Natali Serafin, Renate Strehlau, et al. (+14)
40 [GO] 2022―Jul―25 Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV Frédérique Chammartin, Katharina Kusejko, Chloé Pasin, Alexandra Trkola, Matthias Briel, Patrizia Amico, et al. (+14)
41 [GO] 2022―Jul―22 Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection Michael J. Peluso, Matthew A. Spinelli, Tyler-Marie Deveau, Carrie A. Forman, Sadie E. Munter, Sujata Mathur, et al. (+26)
42 [GO] 2022―Jul―18 Tenofovir disoproxil fumarate and COVID-19 outcomes in men with HIV Guilin Li, Lesley S. Park, Sara Lodi, Roger W. Logan, Emily J. Cartwright, Lydia Aoun Barakat, et al. (+5)
43 [GO] 2022―Jul―18 Impact of the COVID-19 pandemic on prescriptions for antiretroviral drugs for HIV treatment in the United States, 2019-2021 Weiming Zhu, Ya-lin A. Huang, Jeffrey Weiner, Robyn Neblett-Fanfair, Athena P. Kourtis, H. Irene Hall, Karen W. Hoover
44 [GO] 2022―Jul―14 Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV Bezawit A. Woldemeskel, Andrew H. Karaba, Caroline C. Garliss, Evan J. Beck, Tihitina Y. Aytenfisu, Trevor S. Johnston, et al. (+3)
45 [GO] 2022―Jul―14 High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters? Laura Gianserra, Maria Gabriella Donà, Eugenia Giuliani, Christof Stingone, Martina Pontone, Anna Rita Buonomini, et al. (+4)
46 [GO] 2022―Jun―28 Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States Rachel A. Bender Ignacio, Adrienne E. Shapiro, Robin M. Nance, Bridget M. Whitney, Joseph A.C. Delaney, Laura Bamford, et al. (+19)
47 [GO] 2022―Jun―22 Intersecting epidemics: the impact of COVID-19 on the HIV prevention and care continua in the United States Camille E. Spears, Barbara S. Taylor, Albert Y. Liu, Sera M. Levy, Ellen F. Eaton
48 [GO] 2022―Jun―22 Long-lasting adaptive Immune memory specific to SARS-CoV-2 in convalescent COVID-19 Stable People living with HIV Laura Donadeu, Juan Manuel Tiraboschi, Sofía Scévola, Alba Torija, Maria Meneghini, Thomas Jouve, et al. (+10)
49 [GO] 2022―Jun―22 High seroconversion rate and SARS-CoV-2 Delta neutralization in PLWHIV vaccinated with BNT162b2 Valérie Pourcher, Lisa Belin, Cathia Soulie, Michelle Rosenzwajg, Stéphane Marot, Karine Lacombe, et al. (+12)
50 [GO] 2022―Apr―25 Surrogate neutralisation responses following SARS-CoV-2 vaccination in people living with HIV - comparison between inactivated and mRNA vaccine Ngai Sze Wong, Bonnie C.K. Wong, Jacky M.C. Chan, Ka Hing Wong, Owen T.Y. Tsang, Chris K.P. Mok, et al. (+3)
51 [GO] 2022―Mar―24 Toward demystifying HIV as a risk factor for coronavirus disease 2019 complications Alejandro R. Gener, Shyam Kottilil
52 [GO] 2022―Mar―24 Efficacy of sotrovimab for persistent coronavirus disease-2019 in a severely immunocompromised person living with HIV Rocio Montejano, Cristina Marcelo, Iker Falces-Romero, Luis Gonzalez del Valle, Teresa De Soto, Julio Garcia-Rodríguez, Jose R. Arribas
53 [GO] 2022―Feb―24 HIV and SARS-CoV-2 biochemical interactions may not explain clinical outcomes among adults hospitalized with COVID-19 co-infected with HIV: authors’ reply Matthew S. Durstenfeld, Priscilla Y. Hsue
54 [GO] 2022―Jan―27 When pandemics collide: measuring the impact of coronavirus disease 2019 on people with HIV Jeffrey J. Post, Thomas Benfield, Ian Woolley
55 [GO] 2022―Jan―27 High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters? Xinling Xu, Jan Vesterbacka, Soo Aleman, Piotr Nowak
56 [GO] 2022―Jan―11 Impact of COVID-19 epidemics on prevention and care for HIV and other sexually transmitted infections Elisa de Lazzari, Alejandra Martínez-Mimbrero, Iván Chivite, Ana González-Cordón, Maria M. Mosquera, Montserrat Laguno, et al. (+16)
57 [GO] 2022―Jan―11 Impaired antibody response to COVID-19 vaccination in advanced HIV infection Nolan Hassold, Ségolène Brichler, Elise Ouedraogo, Delphine Leclerc, Sophie Carroue, Yamina Gater, et al. (+6)
58 [GO] 2022―Jan―09 Safety and immunogenicity of SARS-CoV-2 mRNA-1273 and BNT162b2 vaccines in people living with HIV Manuel González de Aledo, Angelina Cañizares, Pilar Vázquez-Rodríguez, Ángeles Castro, Luz Moldes, Soledad López, et al. (+3)
59 [GO] 2021―Dec―07 The COVID-19 pandemic and unemployment, 1 subsistence needs and mental health among adults with HIV in the United States Linda Beer, Yunfeng Tie, Sharoda Dasgupta, Tim McManus, Pranesh P. Chowdhury, John Weiser
60 [GO] 2021―Nov―24 SARS-CoV-2 infection and COVID-19 severity in persons with HIV on antiretroviral treatment Julia del Amo, Rosa Polo, Santiago Moreno, Inma Jarrín, Miguel A. Hernán
61 [GO] 2021―Nov―09 Association of human immunodeficiency virus infection with outcomes among adults hospitalized with COVID-19 Matthew S. Durstenfeld, Kaiwen Sun, Yifei Ma, Fatima Rodriguez, Eric A. Secemsky, Rushi V. Parikh, Priscilla Y. Hsue
62 [GO] 2021―Nov―01 COVID-19 in Africa: preexisting immunity and HIV Jumari Snyman, Eduard J. Sanders, Thumbi Ndung’u
63 [GO] 2021―Oct―29 Telemedicine and visit completion among people with HIV during the COVID-19 pandemic compared to pre-pandemic Walid G. El-Nahal, Nicola M. Shen, Jeanne C. Keruly, Joyce L. Jones, Anthony T. Fojo, Bryan Lau, et al. (+5)
64 [GO] 2021―Sep―24 SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV Matthew A. Spinelli, Lillian B. Brown, David V. Glidden, Kyle Hunter, Patrick Martin-Tuite, James Zheng, et al. (+4)
65 [GO] 2021―Sep―02 Recognizing and supporting health workers to advance and sustain HIV gains: lessons from PEPFAR programmes during the COVID-19 response Jerilyn R. Hoover, Diana E. Frymus, Temitayo A. Ifafore-Calfee
66 [GO] 2021―Aug―25 Covid-19 hospitalization outcomes in persons with and without HIV in SPAIN Julián Olalla-Sierra, María Dolores Martín-Escalante, Javier García-Alegría, Manuel Rubio-Rivas, Borja de Miguelcampo, María Zurita-Etayo, et al. (+6)
67 [GO] 2021―Aug―25 SARS-CoV-2 antibody prevalence in people with and without HIV in rural western Kenya, January to March 2020 Trevor A. Crowell, Ibrahim I. Daud, Jonah Maswai, John Owuoth, Valentine Sing’oei, Michelle Imbach, et al. (+5)
68 [GO] 2021―Aug―16 An updated meta-analysis on the association between HIV infection and COVID-19 mortality Yadong Wang, Ruo Feng, Jie Xu, Li Shi, Huifen Feng, Haiyan Yang
69 [GO] 2021―Jul―15 Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV Jake A. Ruddy, Brian J. Boyarsky, Justin R. Bailey, Andrew H. Karaba, Jacqueline M. Garonzik-Wang, Dorry L. Segev, et al. (+2)
70 [GO] 2021―Jun―29 False-positive HIV screening test in a patient with pulmonary embolism because of severe acute respiratory syndrome coronavirus 2 infection Aikaterini Papamanoli, George Psevdos
71 [GO] 2021―Jun―27 The challenging of HIV care one year after of COVID-19 pandemic Juliane Cardoso Villela Santos, Juliana Schaia Rocha Orsi, Victoria Stadler Ribeiro, Felipe Francisco Tuon, João Paulo Telles
72 [GO] 2021―May―16 Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV Jake A. Ruddy, Brian J. Boyarsky, William A. Werbel, Justin R. Bailey, Andrew H. Karaba, Jacqueline M. Garonzik-Wang, et al. (+2)
73 [GO] 2021―May―11 Potential reduction in female sex workers’ risk of contracting HIV during Covid-19 Fortunate Machingura, Sungai Chabata, Joanna Busza, Gracious Jamali, Memory Makamba, Jeffrey Dirawo, et al. (+4)
74 [GO] 2021―May―04 Severe coronavirus disease 2019 in a patient with HIV-2 infection Willem J. Wiersinga, Marc van der Valk
75 [GO] 2021―Mar―12 Tenofovir-based PrEP for COVID-19 Colette DeJong, Matthew A. Spinelli, Hideaki Okochi, Monica Gandhi
76 [GO] 2021―Mar―12 Impact of the COVID-19-related global recession on the financing of the global HIV response Caroline A. Bulstra, Ché L. Reddy, Rifat Atun, Till Bärnighausen, Jan A.C. Hontelez
77 [GO] 2021―Feb―26 Risk of adverse COVID-19 outcomes for people living with HIV Maya M. Mellor, Anne C. Bast, Nicholas R. Jones, Nia W. Roberts, José M. Ordóñez-Mena, Alastair J.M. Reith, et al. (+3)
78 [GO] 2020―Dec―30 Lack of RH2 gene expression may have influenced the HIV pandemic in sub-Saharan Africa Kadimo Nthobatsang, Tshimologo Lone Ncenga, Chipo Mwangi-Woto, Tuelo J. Wedu, Tebogo Gabatlhaolwe, Sikhulile Moyo, et al. (+4)
79 [GO] 2020―Dec―10 Viral suppression not decreased during COVID-19 among people with HIV and unstable housing enrolled in a low-barrier clinic-based program (POP-UP) Matthew D. Hickey, Elizabeth Imbert, David V. Glidden, Jan Bing Del Rosario, Mary Chong, Angelo Clemenzi-Allen, et al. (+4)
80 [GO] 2020―Dec―01 Changes in HIV preexposure prophylaxis prescribing in Australian clinical services following COVID-19 restrictions Michael W. Traeger, Prital Patel, Rebecca Guy, Margaret E. Hellard, Mark A. Stoové
81 [GO] 2020―Nov―29 Caring for people living with HIV during the global COVID-19 pandemic Olivier Nawej Tshikung, Mikaela Smit, Annalisa Marinosci, Hélène Buvelot, Pablo Valladares, Thanh Do-Co Lecompte, et al. (+2)
82 [GO] 2020―Nov―08 The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the U.S. - applying lessons from high-burden settings Lauren F. Collins, Jonathan A. Colasanti, Minh Ly Nguyen, Caitlin A. Moran, Cecile D. Lahiri, Vince C. Marconi, et al. (+2)
83 [GO] 2020―Sep―09 Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19 Matthew A. Spinelli, Matthew D. Hickey, David V. Glidden, Janet Q. Nguyen, Jon J. Oskarsson, Diane Havlir, Monica Gandhi
84 [GO] 2020―Sep―09 Persons living with HIV may be reluctant to access to COVID-19 testing services Francesco Maria Fusco, Vincenzo Sangiovanni, Claudia Tiberio, Nunzia Papa, Luigi Atripaldi, Vincenzo Esposito
85 [GO] 2020―Aug―31 Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? Antonio Di Biagio, Lucia Taramasso, Chiara Dentone, Antonio Vena, Daniele R. Giacobbe, Andrea De Maria, et al. (+2)
86 [GO] 2020―Aug―13 Factors associated with hospital admission for COVID-19 in HIV patients Antonio Di Biagio, Elena Ricci, Leonardo Calza, Nicola Squillace, Barbara Menzaghi, Stefano Rusconi, et al. (+11)
87 [GO] 2020―Aug―13 Characteristics and outcomes of COVID-19 in patients with HIV Yousaf B. Hadi, Syeda F.Z. Naqvi, Justin T. Kupec, Arif R. Sarwari
88 [GO] 2020―Aug―10 HIV infection and COVID-19 Nicolas Etienne, Marina Karmochkine, Laurence Slama, Juliette Pavie, Dominique Batisse, Rafael Usubillaga, et al. (+10)
89 [GO] 2020―Aug―10 Clinical characteristics, risk factors, and incidence of symptomatic COVID-19 in adults living with HIV Alexy Inciarte, Ana Gonzalez-Cordon, Jhon Rojas, Berta Torres, Elisa de Lazzari, Lorena de la Mora, et al. (+13)
90 [GO] 2020―Aug―04 Coinfection of severe acute respiratory syndrome coronavirus 2 and HIV in a teaching hospital: still much to learn Lolita Sasset, Eugenia Di Meco, Silvia Cavinato, Anna M. Cattelan
91 [GO] 2020―Aug―04 Coronavirus disease 2019 in patients with HIV in the province of Araba, Basque Country, Spain Estibaliz Molina-Iturritza, Irene San-José-Muñiz, Maite Ganchegui-Aguirre, Leire Balerdi-Sarasola, Zuriñe Ortiz-de-Zárate-Ibarra, Juan C. Gainzarain-Arana, Joseba Portu-Zapirain
92 [GO] 2020―Jul―23 COVID-19 attack rate in HIV-infected patients and in PrEP users Caroline Charre, Vinca Icard, Pierre Pradat, Corinne Brochier, Bruno Lina, Christian Chidiac, Laurent Cotte
93 [GO] 2020―Jul―23 Preserving two decades of healthcare gains for africa in the Covid-19 era Sonak D. Pastakia, Paula Braitstein, Omar Galárraga, Becky Genberg, Jamil Said, Rajesh Vedanthan, et al. (+2)
94 [GO] 2020―Jul―23 Comorbidity Indices in People with HIV and Considerations for COVID-19 Outcomes Alan Winston, Davide De Francesco, Frank Post, Marta Boffito, Jaime Vera, Ian Williams, et al. (+3)
95 [GO] 2020―Jul―16 Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, GA Lauren F. Collins, Caitlin A. Moran, Nora T. Oliver, Abeer Moanna, Cecile D. Lahiri, Jonathan A. Colasanti, et al. (+6)
96 [GO] 2020―Jul―16 What one pandemic can teach us in facing another Wafaa M. El-Sadr
97 [GO] 2020―Jun―30 Disproportionate burden of COVID-19 among racial minorities and those in congregate settings among a large cohort of people with HIV Eric A. Meyerowitz, Arthur Y. Kim, Kevin L. Ard, Nesli Basgoz, Jacqueline T. Chu, Rocio M. Hurtado, et al. (+10)
98 [GO] 2020―Jun―23 Cases of coronavirus disease-2019 in HIV-infected transgender women Eisuke Adachi, Makoto Saito, Kazuhiko Ikeuchi, Tokio Hoshina, Hiroshi Yotsuyanagi
99 [GO] 2020―Jun―03 Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics Nicolas Dauby
100 [GO] 2020―Jun―03 Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV Harry Coleman, Luke B. Snell, Rebecca Simons, Sam T. Douthwaite, Ming J. Lee
101 [GO] 2020―Jun―03 SARS-CoV-2 infection in a highly experienced person living with HIV Simona Di Giambenedetto, Paola Del Giacomo, Arturo Ciccullo, Angelo Porfidia, Giuseppe De Matteis, Rossella Cianci, et al. (+4)
102 [GO] 2020―Apr―19 Infection of severe acute respiratory syndrome coronavirus 2 in a patient with acquired immunodeficiency syndrome Junwei Su, Xiaomin Shen, Qin Ni, Hong Zhao, Jieru Cai, Biao Zhu, et al. (+4)
 [1] 

102 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.018 sec